Cerebrospinal Fluid Biomarkers for the Diagnosis of Prodromal Alzheimer ’s Disease in Amnestic Mild Cognitive Impairment

Conclusions: CSF biomarkers are very useful tools for the differential diagnosis of prodromal AD in aMCI patients. The concentration of CSF biomarkers is well correlated with the stages of the AD spectrum.Dement Geriatr Cogn Disord Extra 2019;9:100 –113
Source: Dementia and Geriatric Cognitive Disorders Extra - Category: Geriatrics Source Type: research